# FDA 483 - GSK Vaccines GmbH - March 06, 2024

Source: https://www.globalkeysolutions.net/records/483/gsk-vaccines-gmbh/1df7d112-ac75-45f8-aed1-e1e3b1ae54d2

> FDA 483 for GSK Vaccines GmbH on March 06, 2024. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: GSK Vaccines GmbH
- Inspection Date: 2024-03-06
- Product Type: biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [483 - 2024-11-12](https://www.globalkeysolutions.net/records/483/gsk-vaccines-gmbh/b101b4d2-e2cb-4f6d-b47c-fbd0d1013735)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/gsk-vaccines-gmbh/747ff1f5-3469-4102-8e7a-711a9aa3d366)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/unnee-ranjan/43f1d07e-4079-4d33-88a9-baf6a5df932c)
- [Investigator](https://www.globalkeysolutions.net/people/thai-d-truong/7395c128-0adb-44a1-8831-64673c98e93d)

Company: https://www.globalkeysolutions.net/companies/gsk-vaccines-gmbh/af5a9fae-fd5f-4aad-b88d-666e8cf72794

Office: https://www.globalkeysolutions.net/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d